ZDHHC13通过调节代谢物来降低缺血性中风的风险
Zhen Wei1, Chunshu Rong2, Wei He3
1Medical Intensive Care Unit, Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, 130021, China.
棕化基因ZDHHC13通过调节曼酸代谢产物来保护免受缺血性中风 (IS). 较低的ZDHHC13表达与IS风险增加有关,这表明它作为生物标志物的潜力.
科学领域:
- 生物化学 生化学
- 遗传学 是一个遗传学.
- 神经学 神经学
背景情况:
- 棕化在缺血性中风 (IS) 中的作用越来越被认可,但尚未完全理解.
- 需要对棕化基因,代谢物和IS进行系统的调查,以澄清因果关系.
研究的目的:
- 探索棕化基因,代谢物和IS之间的因果关系和潜在机制.
- 为了确定潜在的生物标志物和治疗点为缺血性中风.
主要方法:
- 使用孟德尔随机化 (MR) 分析与GWAS数据用于IS,棕化基因和代谢物.
- 采用了两个样本的MR,基于摘要的门德尔随机化 (SMR) 和调解分析.
- 使用GSE140275数据集和观察性IS患者数据验证基因表达.
主要成果:
- ZDHHC13基因的高表达与IS风险有显著的负相关性.
- ZDHHC13通过调节曼酸代谢产物间接影响IS的发生.
- 观察数据表明IS后ZDHHC13表达减少,与其在中风前的保护作用形成鲜明对比.
结论:
- 通过调节曼诺酸代谢物,ZDHHC13在缺血性中风的进展中起着保护作用.
- ZDHHC13具有作为早期诊断的生物标志物和IS治疗的预防性目标的潜力.
更多相关视频
09:48Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
Published on: May 4, 2015
07:34Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
Published on: December 15, 2023
相关概念视频
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Peripheral Artery Disease III: Interprofessional Care
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
